Published in Genes Immun on March 19, 2009
The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology (2010) 1.64
IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol (2010) 1.59
Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res (2010) 1.32
A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A. Haemophilia (2011) 0.91
Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int (2011) 0.89
Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells. PLoS One (2012) 0.86
Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS. J Acquir Immune Defic Syndr (2010) 0.86
Interleukin-10 (IL-10) pathway: genetic variants and outcomes of HIV-1 infection in African American adolescents. PLoS One (2010) 0.83
Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis (2010) 0.81
Association of IL-10-promoter genetic variants with the rate of CD4 T-cell loss, IL-10 plasma levels, and breadth of cytotoxic T-cell lymphocyte response during chronic HIV-1 infection. Clin Infect Dis (2011) 0.80
Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques. PLoS One (2014) 0.77
Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes. Curr Opin HIV AIDS (2010) 0.76
Polymorphisms in the IFNγ, IL-10, and TGFβ genes may be associated with HIV-1 infection. Dis Markers (2015) 0.75
Immunogenetic influences on acquisition of HIV-1 infection: consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2). Genes Immun (2015) 0.75
Lack of Association between Interleukin-10 Gene Promoter Polymorphisms with HIV Susceptibility and Progression to AIDS. Iran J Pathol (2015) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform (2004) 72.40
Large-scale copy number polymorphism in the human genome. Science (2004) 34.64
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 25.63
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
A common variant associated with prostate cancer in European and African populations. Nat Genet (2006) 13.47
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87
Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol (2004) 10.59
Interleukin-10. Annu Rev Immunol (1993) 10.14
Mitochondrial portraits of human populations using median networks. Genetics (1995) 9.07
Interleukin-10 determines viral clearance or persistence in vivo. Nat Med (2006) 8.01
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05
Evaluating associations of haplotypes with traits. Genet Epidemiol (2004) 5.70
An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet (1997) 5.65
Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med (2006) 4.97
Intraspecific gene genealogies: trees grafting into networks. Trends Ecol Evol (2001) 4.61
ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res (2004) 4.53
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04
Human genes that limit AIDS. Nat Genet (2004) 3.80
Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science (1990) 3.70
Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep (1987) 3.66
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science (1994) 2.92
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med (1995) 2.89
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A (2000) 2.83
Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A (2001) 2.35
Genomics meets HIV-1. Nat Rev Microbiol (2006) 2.34
Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol (1993) 2.28
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol (2001) 2.03
HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95
Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis (2005) 1.89
Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol (2001) 1.84
Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol (1999) 1.62
IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol (1999) 1.55
Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis (2005) 1.55
IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol (1994) 1.46
New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies. Biotechniques (2002) 1.39
Differential regulation of interleukin-10 production by genetic and environmental factors--a twin study. Genes Immun (2002) 1.39
CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol (1996) 1.35
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev (2004) 1.34
HIV-specific IL-10-positive CD8+ T cells are increased in advanced disease and are associated with decreased HIV-specific cytolysis. J Immunol (2006) 1.26
Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun (2004) 1.25
In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol (2008) 1.22
Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun (2005) 1.21
Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Cell Immunol (1997) 1.19
Interleukin-10 and its receptor. Ther Immunol (1994) 1.18
Optimizing human fertility and survival. Nat Med (2001) 1.14
The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev (2002) 1.12
New polymorphisms in the IL-10 promoter region. Genes Immun (2000) 1.09
Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology (2006) 1.06
HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway. Int Immunol (2005) 1.00
Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression. Genes Immun (2003) 1.00
Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Infect Dis (2002) 0.97
A hallmark of balancing selection is present at the promoter region of interleukin 10. Genes Immun (2006) 0.94
Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics (2000) 0.90
Human susceptibility to viral infection: the search for HIV-protective alleles among Africans by means of genome-wide studies. AIDS Res Hum Retroviruses (2006) 0.89
HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV type 1. J Infect Dis (2004) 0.89
Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol (2001) 0.85
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med (1996) 10.62
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science (2001) 8.68
Molecular phylogenetics and the origins of placental mammals. Nature (2001) 8.42
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. Am J Hum Genet (1994) 7.16
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
Ethnic-affiliation estimation by use of population-specific DNA markers. Am J Hum Genet (1997) 6.72
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Tempting fate: control of communicable disease in England. BMJ (1993) 5.62
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature (1996) 5.07
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26
Identification of an amplified, highly expressed gene in a human glioma. Science (1987) 4.21
Mechanism of met oncogene activation. Cell (1986) 4.20
Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science (1986) 4.17
Genetic evidence for two species of elephant in Africa. Science (2001) 4.13
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
Proteins induced by anaerobiosis in Escherichia coli. J Bacteriol (1983) 3.95
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Phytochrome regulation and differential expression of gibberellin 3beta-hydroxylase genes in germinating Arabidopsis seeds. Plant Cell (1998) 3.76
Assessment of the severity of primary depressive illness. Wakefield self-assessment depression inventory. Psychol Med (1971) 3.75
Numt, a recent transfer and tandem amplification of mitochondrial DNA to the nuclear genome of the domestic cat. J Mol Evol (1994) 3.71
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med (1987) 3.58
HLA and AIDS: a cautionary tale. Trends Mol Med (2001) 3.51
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut (2002) 3.48
Comparative anchor tagged sequences (CATS) for integrative mapping of mammalian genomes. Nat Genet (1997) 3.47
Linkage disequilibrium in admixed populations: applications in gene mapping. J Hered (1994) 3.46
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis (2000) 3.20
Genetic basis for species vulnerability in the cheetah. Science (1985) 3.16
Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. Virology (1986) 3.15
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med (1998) 3.15
Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations. Am J Hum Genet (2001) 3.04
Chromosomal organization of the human dihydrofolate reductase genes: dispersion, selective amplification, and a novel form of polymorphism. Proc Natl Acad Sci U S A (1984) 2.99
A genetic linkage map of microsatellites in the domestic cat (Felis catus). Genomics (1999) 2.99
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Identity of the B56.5 protein, the A-protein, and the groE gene product of Escherichia coli. J Bacteriol (1981) 2.82
The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active. Proc Natl Acad Sci U S A (1985) 2.80
A scan for linkage disequilibrium across the human genome. Genetics (1999) 2.79
Proteins induced by aerobiosis in Escherichia coli. J Bacteriol (1983) 2.77
East African cheetahs: evidence for two population bottlenecks? Proc Natl Acad Sci U S A (1987) 2.73
Molecular cloning and expression of a human B-cell growth factor gene in Escherichia coli. Science (1987) 2.65
Segmental aneuploidy as a probe for structural genes in Drosophila: mitochondrial membrane enzymes. Genetics (1973) 2.62
Natural history of HIV-1 cell-free viremia. JAMA (1995) 2.58
HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol (1996) 2.58
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
The GLI-Kruppel family of human genes. Mol Cell Biol (1988) 2.52
Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51
Molecular distance and divergence time in carnivores and primates. Mol Biol Evol (1991) 2.50
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35
General outbreaks of infectious intestinal disease in England and Wales: 1995 and 1996. Commun Dis Public Health (1998) 2.35
Genomic ancestry of the American puma (Puma concolor). J Hered (2000) 2.34
Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans. Am J Hum Genet (2000) 2.32
Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome. Cell (1985) 2.28
Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol (1993) 2.28
Detecting single base substitutions as heteroduplex polymorphisms. Genomics (1992) 2.26
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol (1989) 2.24
Estimation of heterozygosity for single-probe multilocus DNA fingerprints. Mol Biol Evol (1992) 2.23
Effect of HCV, HIV and coinfection in kidney transplant recipients: mate kidney analyses. Am J Transplant (2014) 2.22
A radiation hybrid map of the cat genome: implications for comparative mapping. Genome Res (2000) 2.22
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect (1993) 2.20
A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal Cord (2010) 2.18
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Molecular dating and biogeography of the early placental mammal radiation. J Hered (2001) 2.13
Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr (1992) 2.11